Lilly Cuts Insulin Prices By 70% & Caps Consumer Insulin Out-Of-Pocket Costs At $35 Per Month

Eli Lilly and Company reduced the price of its most commonly prescribed insulins by 70%. It also expanded of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month. Lilly is taking these actions to make it easier to access Lilly insulin and help Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable insulin. In the coming weeks, Lilly will launch a nationwide public awareness campaign to help ensure all Lilly insulin users understand how to access the company's industry-leading affordability solutions.

Lilly . . .